Click Here to return To Results

 

Use of Newer Disease-Modifying Therapies in Pediatric Multiple Sclerosis in the US Neurol 91:e1778-e1787, Krysko, K.M.,et al, 2018 See this aricle in Pubmed Article Abstract No abstract available for this article

Related Tags

(click to filter results - removes previous filter) adverse drug reaction children disease modifying agents efficacy fumarate monoclonal antibodies multiple sclerosis multiple sclerosis,children multiple sclerosis,treatment of natalizumab safety treatment of neurologic disorder

Click Here to return To Results